Supplementary Figure S3 from Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study
Authors:
- Kerry A. RogersKRKerry A. Rogers
- Pearlly YanPYPearlly Yan
- Ian W. FlinnIFIan W. Flinn
- Deborah M. StephensDSDeborah M. Stephens
- Thomas J. KippsTKThomas J. Kipps
- Sarah M. LarsonSLSarah M. Larson
- Laura MartzLMLaura Martz
- Xi ChenXCXi Chen
- Huabao WangHWHuabao Wang
- Ethan HoppingEHEthan Hopping
- Ralf BundschuhRBRalf Bundschuh
- Altan TurkogluATAltan Turkoglu
Open Access
- 15 December 2025
- other
- Published by American Association for Cancer Research (AACR)